We recently compiled a list of the Jim Cramer’s 10 Go-To Stocks for Success. In this article, we are going to take a look at ...

We recently compiled a list of the 12 Best Dividend Stocks For Steady Growth. In this article, we are going to take a look at ...

The maker of blockbuster appetite-suppressing drugs Mounjaro and Zepbound is seeking to end a regulatory designation that has ...

Eli Lilly is cutting the cost of certain weight loss drugs, with new single-dose vials costing less than other medications ...

Eli Lilly (LLY) cuts prices for weight loss drug Zepbound for self-paying customers but raises costs for patients in the ...

Lilly announced that it will now sell Zepbound in vials, too. And a month's supply of vials with the 2.5 mg doses will cost ...

When Eli Lilly & Co. on Tuesday announced pricing and packaging changes for its popular weight-loss drug Zepbound, the ...

The GLP-1 drug giant’s shares have surged this year. Eli Lilly could keep climbing thanks to strong demand for Mounjaro and ...

The cheaper drug will compete with compounded versions of the same medication sold by digital health companies.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 626.12% and ...

Eli Lilly is intensifying its efforts to combat imitation versions of its popular appetite-suppressing drugs, Mounjaro and ...

Eli Lilly may not be an expensive stock when you consider its long-run growth prospects.